Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative study on rat enteromucins

S Ohara1, K Ishihara, K Hotta

  • 1Department of Biochemistry, School of Medicine, Kitasato University, Sagamihara, Japan.

Comparative Biochemistry and Physiology. B, Comparative Biochemistry
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM.

ESMO open·2024
Same author

Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer.

ESMO open·2022
Same author

Corrigendum to 'Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study': [ESMO Open Volume 6, Issue 4, August 2021, 100191].

ESMO open·2022
Same author

Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN.

ESMO open·2022
Same author

First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients.

ESMO open·2022
Same author

Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.

ESMO open·2021

This study analyzed mucus glycoproteins (mucins) across the digestive tract. Regional differences in mucin composition, particularly in sugar content and amino acid ratios, were observed, impacting gastrointestinal mucus structure.

Area of Science:

  • Biochemistry
  • Gastroenterology
  • Glycobiology

Background:

  • Mucus glycoproteins, or mucins, are crucial for protecting the gastrointestinal lining.
  • Understanding regional variations in mucin structure is key to understanding digestive health.

Purpose of the Study:

  • To characterize and compare mucins from different regions of the gastrointestinal tract (duodenum, small intestine, colon).
  • To investigate differences in subunit size, glycopeptide structure, carbohydrate composition, and amino acid ratios.

Main Methods:

  • Extraction of mucins from the duodenum, proximal small intestine, distal small intestine, and colon.
  • Analysis of mucin subunit size, glycopeptide size, carbohydrate composition (sugars and their ratios), and amino acid (threonine/serine) proportions.

Related Experiment Videos

Main Results:

  • Enteromucin subunits were large (>2 x 10^6) with consistent glycopeptide sizes.
  • Carbohydrate composition varied regionally, with different ratios of N-acetylgalactosamine, N-acetylglucosamine, galactose, fucose, and sialic acid.
  • Oligosaccharide length differed, averaging 8 sugars in the duodenum and small intestine, and 14 in the colon.
  • Threonine to serine ratios varied, with duodenal and colonic mucins being richer in threonine than small intestinal mucins.
  • Rat enteromucins showed larger subunits/glycopeptides and higher threonine/sialic acid content compared to gastromucins.

Conclusions:

  • Significant regional variations exist in gastrointestinal mucin structure and composition.
  • These compositional differences likely contribute to region-specific functions of mucus in the digestive system.
  • Enteromucins exhibit distinct structural features compared to gastromucins, highlighting specialized adaptations along the GI tract.